Gsa Capital Partners LLP Biocept Inc Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.43 - $4.22 $317,751 - $390,936
-92,639 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$3.39 - $4.34 $199,647 - $255,595
-58,893 Reduced 38.87%
92,639 $371,000
Q2 2021

Aug 05, 2021
BUY
$4.03 - $5.07 $453,318 - $570,304
112,486 Added 288.09%
151,532 $635,000
Q1 2021

May 10, 2021
BUY
$4.74 - $7.94 $185,078 - $310,025
39,046 New
39,046 $199,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email